MedTrace Logo

Directly Administered HIV Therapy in Methadone Clinics

NCT00279110 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2015-04-15

No results posted yet for this study

Summary

The purpose of this study is to determine whether providing directly administered antiretroviral therapy to HIV-infected who receive methadone therapy leads to better treatment outcomes than if they take HIV medications on their own.

Conditions

  • HIV Infections
  • Heroin Dependence

Interventions

BEHAVIORAL

Directly administered antiretroviral therapy (DAART)

Participants are observed taking HIV medications on days when they receive opioid agonist therapy.

Sponsors & Collaborators

Principal Investigators

  • Gregory M. Lucas, MD, PhD · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00279110 on ClinicalTrials.gov